CIM Investment Management’s Elevance Health ELV Stock Holding History

CIM Investment Management’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$307K	Sell	1,048 -5	-0.5%	-$1.64K	0.08%	196
2025 Q4	$369K	Hold	1,053	–	–	0.1%	163
2025 Q3	$340K	Sell	1,053 -1,080	-51%	-$336K	0.09%	170
2025 Q2	$808K	Buy	2,133 +1,065	+100%	+$428K	0.15%	126
2025 Q1	$465K	Sell	1,068 -1	-0.1%	-$401	0.11%	124
2024 Q4	$394K	Buy	1,069 +5	+0.5%	+$2.09K	0.12%	147
2024 Q3	$553K	Sell	1,064 -19	-2%	-$10.2K	0.16%	112
2024 Q2	$587K	Sell	1,083 -6	-0.6%	-$3.17K	0.18%	111
2024 Q1	$565K	Hold	1,089	–	–	0.17%	117
2023 Q4	$514K	Hold	1,089	–	–	0.17%	125
2023 Q3	$474K	Sell	1,089 -26	-2%	-$11.8K	0.17%	121
2023 Q2	$495K	Buy	1,115 +2	+0.2%	+$923	0.17%	120
2023 Q1	$512K	Buy	1,113 +54	+5%	+$25.7K	0.19%	118
2022 Q4	$543K	Sell	1,059 -31	-3%	-$15.7K	0.21%	104
2022 Q3	$495K	Hold	1,090	–	–	0.22%	101
2022 Q2	$526K	Sell	1,090 -6	-0.5%	-$2.97K	0.22%	103
2022 Q1	$538K	Sell	1,096 -1	-0.1%	-$457	0.18%	113
2021 Q4	$509K	Sell	1,097 -20	-2%	-$8.41K	0.15%	143
2021 Q3	$416K	Sell	1,117 -7	-0.6%	-$2.66K	0.13%	156
2021 Q2	$429K	Sell	1,124 -7	-0.6%	-$2.67K	0.13%	155
2021 Q1	$406K	Sell	1,131 -43	-4%	-$13.8K	0.13%	163
2020 Q4	$377K	Sell	1,174 -19	-2%	-$5.83K	0.12%	172
2020 Q3	$320K	Sell	1,193 -120	-9%	-$32.3K	0.12%	163
2020 Q2	$345K	Hold	1,313	–	–	0.14%	146
2020 Q1	$298K	Buy	1,313 +42	+3%	+$11.4K	0.15%	132
2019 Q4	$384K	Hold	1,271	–	–	0.15%	138
2019 Q3	$305K	Buy	+1,271	New	+$348K	0.11%	227
2019 Q1	–	Sell	-2,664	Closed	-$700K	–	318
2018 Q4	$700K	Sell	2,664 -110	-4%	-$30.2K	0.3%	63
2018 Q3	$760K	Sell	2,774 -2	-0.1%	-$519	0.27%	76
2018 Q2	$661K	Sell	2,776 -79	-3%	-$18.3K	0.23%	107
2018 Q1	$627K	Sell	2,855 -71	-2%	-$16.7K	0.21%	122
2017 Q4	$658K	Sell	2,926 -45	-2%	-$9.58K	0.22%	118
2017 Q3	$564K	Sell	2,971 -162	-5%	-$30.8K	0.2%	131
2017 Q2	$589K	Sell	3,133 -3,226	-51%	-$580K	0.21%	126
2017 Q1	$1.05M	Sell	6,359 -608	-9%	-$96.7K	0.36%	50
2016 Q4	$1M	Buy	6,967 +81	+1%	+$10.8K	0.36%	58
2016 Q3	$863K	Sell	6,886 -540	-7%	-$69.7K	0.33%	73
2016 Q2	$975K	Sell	7,426 -10	-0.1%	-$1.37K	0.4%	60
2016 Q1	$1.03M	Sell	7,436 -892	-11%	-$119K	0.45%	52
2015 Q4	$1.16M	Hold	8,328	–	–	0.53%	51
2015 Q3	$1.17M	Hold	8,328	–	–	0.56%	47
2015 Q2	$1.37M	Hold	8,328	–	–	0.6%	44
2015 Q1	$1.29M	Hold	8,328	–	–	0.56%	45
2014 Q4	$1.05M	Hold	8,328	–	–	0.48%	70
2014 Q3	$996K	Sell	8,328 -411	-5%	-$47.1K	0.51%	73
2014 Q2	$940K	Sell	8,739 -256	-3%	-$26.4K	0.47%	82
2014 Q1	$895K	Sell	8,995 -222	-2%	-$20.1K	0.41%	88
2013 Q4	$852K	Buy	9,217 +630	+7%	+$56K	0.43%	104
2013 Q3	$718K	Sell	8,587 -1,035	-11%	-$88.7K	0.43%	102
2013 Q2	$787K	Buy	+9,622	New	+$720K	0.47%	80

Other funds holding ELV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return

CIM Investment Management's ELV Position: Q1 2026 in Review

CIM Investment Management reduced its Elevance Health (ELV) stake by 0.47% in Q1 2026, selling an estimated $1.64K and leaving 1,048 shares worth $307K. The position accounts for 0.08% of the portfolio, ranked #196.

CIM Investment Management first reported a position in ELV in Q2 2013 and has held it in 50 quarters since. The position peaked at $1.37M in Q2 2015. 1,469 funds tracked by Wall St. Rank hold ELV as of Q1 2026.

CIM Investment Management held 1,048 shares of Elevance Health worth $307K as of Q1 2026.
CIM Investment Management sold 5 Elevance Health shares in Q1 2026, an estimated $1.64K.
Elevance Health made up 0.08% of CIM Investment Management's portfolio in Q1 2026, its #196 holding.
CIM Investment Management first reported a position in Elevance Health in Q2 2013 and has held it in 50 quarters since.
CIM Investment Management's Elevance Health position peaked at $1.37M in Q2 2015.
1,469 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.

Based on CIM Investment Management's 13F filing for Q1 2026, filed 19 May 2026.